September 26, 2007 - GlucoLight Corporation, a development-stage company focused on blood glucose monitoring in the acute care environment, announced that it has been awarded U.S. Patent No. 7,254,429 for the technology that is the core of the company’s first product, the Sentris-100™ glucose monitor... Sentris-100 is currently in clinical testing and the Company recently completed its first hypoglycemic “clamping study” that measured blood glucose fluctuations in volunteer subjects with Type 1 diabetes..... GlucoLight's Press Release -
Showing posts with label GlucoLight. Show all posts
Showing posts with label GlucoLight. Show all posts
Friday, September 28, 2007
GlucoLight, Patent for Sentris-100™ Blood Glucose Monitoring Technology
September 26, 2007 - GlucoLight Corporation, a development-stage company focused on blood glucose monitoring in the acute care environment, announced that it has been awarded U.S. Patent No. 7,254,429 for the technology that is the core of the company’s first product, the Sentris-100™ glucose monitor... Sentris-100 is currently in clinical testing and the Company recently completed its first hypoglycemic “clamping study” that measured blood glucose fluctuations in volunteer subjects with Type 1 diabetes..... GlucoLight's Press Release -
Monday, September 3, 2007
GlucoLight, first hypoglycemic clamping study of its continuous, non-invasive glucose monitor, Sentris-100
August 22, 2007 - GlucoLight Corporation, company focused on blood glucose monitoring in the acute care environment, announced the successful conclusion of the company’s first hypoglycemic “clamping” study to evaluate its continuous, non-invasive glucose monitor, Sentris-100™. - GlucoLight's Press Room (PDF) -
Subscribe to:
Posts (Atom)
